Drug use Prevalence among Former SSI DA&A Recipients

Abstract

This paper examines illegal drug use prevalence among former recipients of Supplemental Security Income (SSI) disability benefits for drug addiction and alcoholism (DA&A) in Chicago, Los Angeles, and Seattle, based on urinalysis and self-report data. It presents estimates of current prevalence (past three days) for four categories of illegal drugs–-opiates, cocaine, marijuana, or any use–-at 12 and 24 months after termination of the DA&A program. Data were obtained as part of a longitudinal study of 1,764 former SSI DA&A recipients in nine sites. Analyses indicate that a substantial number of former DA&A recipients, probably 45%–55%, were engaged in active drug use after termination of the program. Among users, cocaine and opiate use were extensive. Although there were high rates of underreporting by self-reported non-users, underreporting was not systematically associated with age, gender, ethnicity, criminal justice involvement, recent substance abuse treatment, or SSI benefit status.

Get full access to this article

View all access options for this article.

References

Anglin

M. Douglas

, Caulkins

Jonathan P.

and Hser

Yih-Ing

(1993). Prevalence estimation: Policy needs, current status, and future potential. Journal of Drug Issues, 23(2), 345–360.

Anglin

M. Douglas

, Haikang

Shen

, Yin-Ing

Hser

, and Brecht

Mary Lynn

(1999). Drug use prevalence estimates among adult arrestees in California, Texas, and the U.S. Los Angeles, CA: University of California, Los Angeles, Drug Abuse Research Center. Report prepared for the National Evaluation and Data Technical Assistance Center of the Center for Substance Abuse Treatment.

Choudhry

G. Hussain

and Helba

Cynthia

(2003). Rationale and procedures for weighting the SSI Study data, Contemporary Drug Problems, JO, 137–146.

Cone

Edward J.

(1997). New developments in biological measures of drug prevalence, NIDA Research Monograph, 167, 108–129.

Fendrich

Michael

and Vaughn

Connie M.

(1994). Diminished lifetime substance use over time: An inquiry into differential underreporting. Public Opinion Quarterly, 58, 96–123.

Harrison

Lana

(1997). The validity of self-reported drug use in survey research: An overview and critique of research methods. NIDA Research Monograph, 167, 17–36.

Hser

Yih-Ing

(1997). Self-reported drug use: Results of selected empirical investigations of validity. NIDA Research Monograph, 167, 320–343.

Hser

Yih-Ing

Prendergast

Michael

, Anglin

M. Douglas

, Chen

Jane K.

, and Hsieh

Shih-Chao

(1998). A regression analysis estimating the number of drug-using arrestees in 185 U.S. Cities. American Journal of Public Health, 880), 487–490.

Magura

Stephen

and Kang

Sung-Yeon

(1997). The validity of self-reported cocaine use in two high-risk populations. NIDA Research Monograph, 167, 227–246.

10.

Maxwell

Jane Carlisle

(2000). Methods for estimating the number of “hard core” drug users. Substance Use and Misuse, 35(3), 399–420.

11.

Nurco

David N.

(1985). A discussion of validity. National Institute on Drug Abuse Research Monograph Series, 57, 4–11.

12.

Reuter

Peter

(1993). Prevalence estimation and policy formulation. Journal of Drug Issues, 23(2), 167–184.

13.

Rhodes

William

(1993). Synthetic estimation applied to the prevalence of drug use. Journal of Drug Issues 23(2), 297–322.

14.

Swartz

James

, Peggy

Tonkin

and Baumohl

Jim

(2003). The methodology of the multi-site study of the termination of Supplemental Security Income benefits for drug addicts and alcoholics. Contemporary Drug Problems, 30, 77–121.

15.

Wish

Eric D.

, Hoffman

Jeffrey A.

, and Nemes

Susanna

(1997). The validity of self-reports of drug use at treatment admission and at followup: Comparisons with urinalysis and hair assays. NIDA Research Monograph, 167, 200–225.